While only six stocks globally have cracked the trillion-dollar mark, each a titan in its field, the intrigue surrounding this milestone is irresistible. Investors continuously seek the next contender primed to surge past this valuation. Achieving such a monumental market cap demands astute leadership, diverse and expanding revenue streams, and a clear vision for both short and long-term company growth.
Aside from factors like fortune and market fluctuations, a select group of companies exhibit the potential to ascend to trillion-dollar status. Whether through solid fiscal frameworks, industry domination, or reputations as stalwart providers in burgeoning sectors, these firms are poised to make their mark.
Let’s delve into the up-and-comers destined for trillion-dollar valuations and why considering an investment in them now could be advantageous.
Berkshire Hathaway Inc. Class B (BRK-B)
Source: sdx15 / Shutterstock.com
Berkshire Hathaway (NYSE: BRK-B) epitomizes the perks of diversification. This multinational conglomerate thrives on its primary insurance focus (comprising both underwriting and investments) while holding stakes in diverse industries from railroads to energy, gas stations, retail, and manufacturing. Heading this powerhouse is Warren Buffet, often hailed as the investment sage of our era.
After closing 2022 in the red, the 2023 financials paint a rosy picture for Berkshire Hathaway. While insurance revenue saw a 5% uptick, other segments posted nearly doubled revenues year-over-year. Notably, investments and derivatives reclaimed their footing, boasting a $74.86 billion gain after a $67.89 billion loss the previous year.
Market interest in BRK-B peaked on February 26, 2024, propelling its valuation past the $900 billion mark with shares hitting an all-time high of $430. The looming possibility of breaching $1 trillion is within reach, potentially making Berkshire Hathaway the inaugural non-tech U.S. firm to join this illustrious club.
Buffet’s annual letter curbed short-term growth expectations while exuding confidence in the company’s resilience. “I believe Berkshire can handle financial disasters of a magnitude beyond any heretofore experienced,” Buffet remarked, lauding the firm’s strong financial stance and diverse investments.
Evidence of this stability lies in BRK-B’s financial report, showcasing a record $167.64 billion in cash and cash equivalents by the close of 2023, including short-term U.S. Treasury bill investments. “Berkshire,” Buffet affirmed, “is built to last.”
Eli Lilly and Company (LLY)
Source: Jonathan Weiss / Shutterstock.com
Eli Lilly and Company (NYSE: LLY) emerges as the pharmaceutical behemoth of our time, boasting a market capitalization eclipsing $750 billion. While renowned for medications targeting diabetes and clinical depression, the company offers over 50 drugs to global consumers.
LLY’s recent report unveiled a notable $2.19 billion revenue surge driven by new products, prominently Mounjaro and Zepbound, accounting for roughly a quarter of total revenue. Quarterly revenues soared to $9.35 billion, reflecting a robust 28% YOY growth, while GAAP EPS met analyst estimates at $2.42, a 13% YOY gain.
Zepbound, a weight-loss injection garnering massive attention post-FDA approval, has raked in $175.8 million in its debut selling quarter, with substantial room for growth as LLY ramps up production and distribution.
Analysts share the enthusiasm surrounding Zepbound’s prospects, with Morgan Stanley forecasting $2.2 billion in 2024 revenues and Bank of America presenting a more bullish $2.7 billion estimate. Noteworthy performers like Verzenio and Tyvyt further fuel investor optimism, hinting at LLY’s potential ascent to trillion-dollar prominence.
Taiwan Semiconductor (TSM)
The Path to Trillion-Dollar Status: Analyzing Taiwan Semiconductor’s (TSM) Market Performance
Understanding the Pandemic Chip Shortage Phenomenon
The pandemic, a time that significantly challenged global supply chains, brought forth a fascinating conundrum in the semiconductor industry – the chip shortage. This event spurred chip manufacturers such as Taiwan Semiconductor (NYSE: TSM) to soar in market capitalization, attracting a throng of investors eager to partake in meeting the skyrocketing demands caused by the shortage.
Taiwan Semiconductor’s Market Volatility
In 2022, TSM triumphantly breached the $700 billion milestone, only to experience a subsequent decline in prices towards levels slightly robust than pre-pandemic norms. Presently, the stock is climbing back towards its pandemic peak values, with TSM’s market capitalization hovering around $656 billion, paving the way for potential growth towards trillion-dollar status.
The Client Base Advantage: A Key Factor in TSM’s Potential Success
A crucial aspect that fuels my optimism about Taiwan Semiconductor’s journey towards becoming a trillion-dollar entity is its impressive clientele roster. TSM serves as the leading producer of integrated circuits for prominent tech giants like Broadcom (NASDAQ: AVGO), Intel (NASDAQ: INTC), Qualcomm (NASDAQ: QCOM), Apple (NASDAQ: AAPL), and Nvidia (NASDAQ: NVDA). Notably, TSM’s 3-nanometer N3 chips stand at the pinnacle of the industry, with plans underway for the production of cutting-edge 2nm N2 chips slated for a 2025 debut.
Continued Growth Trajectory Amidst Tech Sector Evolution
Although the chip shortage episode may have subsided, the escalating demand for artificial intelligence (AI) technology remains a driving force propelling growth in the tech domain. Taiwan Semiconductor foresees a substantial 20% surge in revenue by 2024, mirroring the ongoing technological advancements influencing the industry landscape.
On the date of publication, Rick Orford did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
